Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Operating Expenses | 23,200 | 36,700 | 29,050 | 19,110 | 14,120 |
| Operating Income | -23,200 | -36,700 | -29,050 | -19,110 | -14,120 |
| Other Income | 350 | 340 | -300 | -270 | -140 |
| Pre-tax Income | -22,850 | -36,360 | -29,350 | -19,380 | -14,260 |
| Income Tax | 5 | 30 | 40 | 8 | 10 |
| Net Income Continuous | -26,160 | -35,425 | -28,641 | -19,974 | -16,231 |
| Net Income | $-22,850 | $-36,390 | $-29,390 | $-19,390 | $-14,280 |
| EPS Basic Total Ops | -2.94 | -4.46 | -3.89 | -3.04 | -3.13 |
| EPS Basic Continuous Ops | -2.97 | -4.42 | -3.84 | -3.04 | -3.13 |
| EPS Diluted Total Ops | -2.94 | -4.46 | -3.89 | -3.04 | -3.13 |
| EPS Diluted Continuous Ops | -2.97 | -4.42 | -3.84 | -3.04 | -3.13 |
| EBITDA(a) | $-23,080 | $-36,600 | $-28,960 | $-19,050 | $-13,910 |